AIC
BIO icon

Archer Investment Corporation’s Bio-Rad Laboratories Class A BIO Stock Holding History

Archer Investment Corporation’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$692 – 1086
2024
Q1 		$692 Hold
2
– – ﹤0.01% 974
2023
Q4 		$646 Hold
2
– – ﹤0.01% 988
2023
Q3 		$717 Hold
2
– – ﹤0.01% 950
2023
Q2 		$758 Hold
2
– – ﹤0.01% 932
2023
Q1 		$958 Hold
2
– – ﹤0.01% 784
2022
Q4 		$841 Hold
2
– – ﹤0.01% 764
2022
Q3 		$834 Hold
2
– – ﹤0.01% 740
2022
Q2 		$990 Hold
2
– – ﹤0.01% 737
2022
Q1 		$1.18K Hold
2
– – ﹤0.01% 732
2021
Q4 		$1.51K Buy
+2
New +$1.5K ﹤0.01% 701

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Archer Investment Corporation's BIO Position: Q2 2024 in Review

Archer Investment Corporation sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 2 shares — an estimated $692 sold.

Archer Investment Corporation first reported a position in BIO in Q4 2021 and held it in 10 quarters. The position peaked at $1.51K in Q4 2021. 440 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Archer Investment Corporation reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Archer Investment Corporation sold 2 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $692.
  • Archer Investment Corporation first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 10 quarters.
  • Archer Investment Corporation's Bio-Rad Laboratories Class A position peaked at $1.51K in Q4 2021.
  • 440 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Archer Investment Corporation's 13F filing for Q2 2024, filed 2 Aug 2024.